Eagle Capital Management (Louisiana)’s AbbVie ABBV Stock Holding History

Eagle Capital Management (Louisiana)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-870	Closed	-$201K	–	50
2025 Q3	$201K	Buy	+870	New	+$177K	0.08%	49
2018 Q4	–	Sell	-34,102	Closed	-$3.23M	–	34
2018 Q3	$3.23M	Buy	34,102 +769	+2%	+$72.9K	1.82%	24
2018 Q2	$3.09M	Buy	33,333 +429	+1%	+$41.9K	1.95%	22
2018 Q1	$3.11M	Sell	32,904 -8,984	-21%	-$987K	2.17%	18
2017 Q4	$4.05M	Sell	41,888 -459	-1%	-$43.3K	2.18%	10
2017 Q3	$3.76M	Sell	42,347 -320	-0.7%	-$24.4K	2.15%	11
2017 Q2	$3.09M	Sell	42,667 -525	-1%	-$35.3K	1.84%	14
2017 Q1	$2.81M	Buy	43,192 +512	+1%	+$32.2K	1.73%	22
2016 Q4	$2.67M	Sell	42,680 -796	-2%	-$48.6K	1.75%	29
2016 Q3	$2.74M	Buy	+43,476	New	+$2.81M	2.03%	27

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Eagle Capital Management (Louisiana)'s ABBV Position: Q4 2025 in Review

Eagle Capital Management (Louisiana) sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 870 shares — an estimated $201K sold.

Eagle Capital Management (Louisiana) first reported a position in ABBV in Q3 2016 and held it in 10 quarters. The position peaked at $4.05M in Q4 2017. 4,145 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Eagle Capital Management (Louisiana) reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
Eagle Capital Management (Louisiana) sold 870 AbbVie shares in Q4 2025, an estimated $201K.
Eagle Capital Management (Louisiana) first reported a position in AbbVie in Q3 2016 and held it in 10 quarters.
Eagle Capital Management (Louisiana)'s AbbVie position peaked at $4.05M in Q4 2017.
4,145 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Eagle Capital Management (Louisiana)'s 13F filing for Q4 2025, filed 12 Jan 2026.